Disclaimer: Protocols discussed are derived from clinical data and are intended solely for educational use under the guidance of Dr. Igor I. Bussel, MD. These peptides are not currently FDA-approved for human therapeutic use and are prohibited by WADA/USADA for competitive athletes.

Pillar Guide v2.4

The Wolverine Protocol Index
Accelerated Recovery Methodology.

A methodology for accelerated recovery through the synergistic application of BPC-157 and TB-500.

Human RCTs

Limited

Evidence Grade

B- Grade

WADA Status

Banned

Primary Mechanism

Angiogenesis

01. Methodology Overview

The Wolverine Stack methodology relies on the biological synergy between BPC-157's angiogenic properties (creating new blood vessels) and TB-500's action on actin upregulation (cellular migration). Together, they target the three phases of tissue repair:

  1. Inflammatory Phase: Modulation of acute cytokine response.
  2. Proliferative Phase: Accelerated fibroblast migration and collagen synthesis.
  3. Remodeling Phase: Structural reinforcement of newly formed tissue.

Eligibility & Oversight

  • Documented soft tissue injury (tendon, ligament, muscle)
  • Baseline metabolic blood panel
  • Active supervision by a licensed clinician or specialist

02. Component Architecture

Gastric Pentadecapeptide BPC-157

The Systemic Shield

Derived from human gastric juice, this peptide is highly stable and targets the G-H axis to facilitate blood vessel growth (angiogenesis).

  • Collagen expression focus
  • Gastric stability (Oral viable)
Thymosin Beta-4 Fragment TB-500

The Cellular Architect

A synthetic fragment of a naturally occurring protein found in high concentrations in platelets and wound fluid.

  • Cell migration & Actin focus
  • Systemic inflammation management

03. Protocol Comparison Grid

Phase Timeline Description Oversight
Phase 0 (Intake) Days 1-14 Comprehensive lab work and physician consultation. Mandatory MD review.
Phase 1 (Loading Phase) Weeks 1-4 Initiation of localized BPC-157 alongside systemic TB-500 to address acute inflammation. Weekly symptom monitoring.
Phase 2 (Maintenance) Weeks 5-12 Tapered protocol focused on deep tissue remodeling. Monthly metabolic panel check.

Safety & Regulatory Matrix

Regulatory Red Flags

  • 01. WADA S2 Category: TB-500 is banned at all times for tested athletes.
  • 02. Research-Only Status: Not approved by the FDA for human administration.

Biological Risks

  • ! Angiogenesis Risk: High doses theorized to potentially feed existing occult malignancies.
  • ! Purity Issues: Heavy metal contamination in non-verified "research chemical" batches.
Find a Verified Protocol Clinic

Connect with certified specialists under Dr. Bussel's guidance.

Consult Now

06. Practitioner FAQ

Primary Literature & Sources

View Full Database

[1] BPC-157 as a therapeutic agent in muscle/tendon healing

J. Orthop. Res (2021)

[2] Thymosin β4 facilitates repair of rat Achilles tendon

Wound Repair Regen (2018)
DR. BUSSEL

Medically Reviewed by Igor I. Bussel, MD

"This content is maintained according to our Clinical Accuracy Standards. We grade evidence from Human RCT to Mechanistic Hypothesis to ensure athletes are not making health decisions based on bro-science."

Board Certified Physician Updated Quarterly